Zai Lab
ZLAB
Zai Lab (ZLAB) news
Recent news
Zai Lab and Argenx announce positive top-line results from Phase 3 Alkivia trial of efgartigimod in autoimmune myositis
AInvest Wire · Aug 17, 2026Zai Lab - Q2 2026 net loss $50.80 mln, loss per share $0.05, loss per ADS $0.46
AInvest Wire · Aug 6, 2026Zai Lab - Q2 2026 total revenue $106.30 mln vs $110 mln in Q2 2025
AInvest Wire · Aug 6, 2026Zai Lab 2Q loss per ADS 46c vs. loss/SHR 37c Y/Y
AInvest Wire · Aug 6, 2026Hong Kong biotech stocks rose in choppy trading; 09688.HK and 02197.HK gained over 6.5%, 09926.HK and 06127.HK climbed more than 5%, while 01349.HK and 01541.HK also advanced.
Hong Kong biotech stocks experienced a mixed session on June 17, 2026, with several key names posting gains amid ongoing investor interest in the sector. Zai Lab Limited (09688.HK) rose over 6.5%, trading within a day’s range of 13.850 to 14.580, with market capitalization of approximately $16.168…
AInvest Wire · Jun 18, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.